Deep insights & analyses

Insights

Dive into comprehensive insights and analyses from Volv Global on the intersection of healthcare trends, innovations, and AI technology.

MASH/NASH: Why Therapeutic Breakthroughs Demand a New Era of Patient Identification

By Léon Van Wouwe, Clinical Innovation Director, Volv Global Introduction: A Silent Disease Becoming a Public Health Emergency Metabolic

By Léon Van Wouwe, Clinical Innovation Director, Volv Global Knowing When To Treat – AI for Transformation, Infection Risk, and

By Léon Van Wouwe, Clinical Innovation Director, Volv Global Early detection and personalised treatment in chronic lymphocytic leukaemia (CLL) remain

Artificial intelligence continues to redefine clinical development yet much of the conversation remains driven by hype rather than hard evidence.

Volv Global continues to shape the future of AI in healthcare. This November, at Frontiers Health 2025 in Berlin, CEO

By Léon Van Wouwe, Clinical Innovation Director, Volv Global A Hidden Cancer in Plain Sight Multiple myeloma (MM) has